Yvonne Linney

Yvonne Linney is an experienced board member and strategic advisor in the life sciences sector, currently serving on the boards of Sengenics and Bionano Genomics, Inc., while providing strategic advisory services through Linney BioConsulting. With a background that includes leadership roles such as Chief Operating Officer at Artificial, Inc. and CEO at Strateos, Yvonne has a proven track record in operational management and strategy development. Previous experience includes key positions at Agilent Technologies and Siemens Healthcare, where Yvonne contributed to significant advancements in life sciences and molecular diagnostics. Yvonne holds a PhD in Genetics from the University of Leicester and a BSc in Microbiology & Virology from the University of Warwick.